|
Report | Age | PT type | Size (mm) |
Associated carcinoma |
Location of carcinoma relative to PT | Comment | Outcome |
Invasive | In situ | | | |
|
Yamaguchi et al. [4] | 54 | BPT | 150 | | DCIS | Within | | AW at 11 months |
Ramdass and Dindyal [5] | 69 | BPT | NS | IDC | | Within | Complex carcinoma with clear cell, secretory and squamous differentiation | NA |
|
Parfitt et al. [1] | 26 | BPT | 33 | IDC | DCIS | Within | Metastatic adenocarcinoma in 4 of 13 LN | AW at 36 months |
|
Kodama et al. [6] | 47 | BPT | 170 | ILC | DCIS | Within | Lump present for 12 years before treatment | AW at 108 months |
|
De Rosa et al. [7] | 77 | BPT* | 50 | IDC | DCIS | Ipsilateral | Mild atypia in stroma with occasional mitoses | AW at 10 months |
Yasumura et al. [8] | 47 | BPT | 130 | IDC | | Within | | AW at 66 months |
Knudsen and Ostergaard [9] | 71 | BPT | 70 | | DCIS, LCIS | Within | | NA |
Grove and Deibjerg Kristensen [10] | 71 | BPT | 190 | | DCIS | Within | History of irradiation to ovaries for climacteric menstrual disorders | AW at 4 months |
|
Christensen et al. [11] | 42–58 | BPT | 10–20 | IDC | | Ipsilateral | IDC in close relation to a recurrent PT | RIP after 3 months from metastatic carcinoma |
Ishida et al. [12] | | BPT | 56 | Papillotubular | | Within | | AW at 30 months |
|
Stone-Tolin et al. [13] | 59 | BPT/NS | 220 | IDC | | Contralateral | Recurring PT and FA over 36-year period | AW at 15 months |
|
Leong and Meredith [14] | 47 | BPT | 40 | ITC | | Within | Three recurrences of BPT. LCIS in second recurrence and ITC in third recurrence | AW at 21 months |
|
Richards and WAY [15] | 37 | BPT | 70 | IDC** | | Ipsilateral | Separate tumour nodules. Metastatic carcinoma in LN | RIP after 9 months from metastases† |
|
Lester and Stout, [16] | 40 | BPT | 14 | NS | NS | Ipsilateral | PT found in mastectomy specimen performed for carcinoma | AW at 144 months |
Tan et al. [17] | NA | NS∞ | NA | | DCIS | Ipsilateral | | NA |
Tan et al. [17] | NA | NS∞ | NA | | LCIS | Within | | NA |
Deodhar et al. [18] | 51 | BLPT | 140 | | DCIS | Within, Ipsilateral | | NA |
Christensen et al. [11] | 42–58 | BLPT | NS | | DCIS | Within, Ipsilateral | | RIP after 36 months from unrelated cause |
Christensen et al. [11] | 42–58 | BLPT | NS | | DCIS | Ipsilateral | Recurrent PT associated with DCIS in adjacent breast within 12 months of initial diagnosis | RIP after 12 months from metastatic PT |
|
Korula et al. [19] | 51 | MPT | 210 | | DCIS | Within, Ipsilateral | Metastatic carcinoma in 2 of 12 lymph nodes | AW at 11 months |
Kefeli et al. [20] | 26 | MPT | 45 | IDC | | Ipsilateral | Liposarcomatous and chondrosarcomatous stroma in PT; history of osteosarcoma and radiotherapy | RIP after 12 months‡ |
|
Sugie et al. [21] | 54 | MPT | 60 | IDC | DCIS | Within | Carcinoma showed squamous differentiation | RIP after 40 months from metastatic PT |
|
Merck et al. [22] | NS | MPT | NS | IDC | | Contralateral | | AW at 32 months |
Nomura et al. [23] | 75 | MPT | 35 | | DCIS | Within | | AW at 32 months |
Lim and Tan [24] | 45 | MPT | 120 | | DCIS | Within | Liposarcomatous differentiation in PT; two FAs in contralateral breast | RIP after 108 months from unrelated cause |
|
Tan et al. [17] | NS | MPT | NS | | DCIS | Within | | |
Auerbach [25] | 69 | MPT | NS | IDC | | Ipsilateral | PT recurred after 40 months with metastases | RIP after 51 months from metastases† |
|
Gebrim et al. [26] | 58 | MPT | 300 | ILC | | Contralateral | ILC within FA in contralateral breast | AW at 84 months |
|
Nishimura et al. [27] | 80 | MPT | 105 | | DCIS | Within | Osteosarcomatous, rhabdomyosarcomatous, fibrosarcomatous stroma in PT | RIP after 3 months from metastases† |
|
Padmanabhan et al. [28] | 47 | MPT | 75 | | LCIS | Within | Liposarcomatous and fibrosarcomatous stroma in PT | AW at 6 months |
|
Kasami et al. [29] | 47 | MPT | NS | ILC | | Contralateral | 46XX/46XY mosaic karyotype; three sisters with breast carcinoma. Recurrent PT at autopsy | NA |
|
Powell and Rosen [30] | 17–71 | MPT | 8–100 | | DCIS | Ipsilateral | Liposarcomatous stroma in PT | NA |
|
Powell and Rosen [30] | 17–71 | MPT | 8–100 | | LCIS | Contralateral | Liposarcomatous stroma in PT | NA |
|
Powell and Rosen [30] | 17–71 | MPT | 8–100 | IDC | DCIS | Ipsilateral, Contralateral | Initially BPT, recurred as MPT with liposarcomatous differentiation in PT; Ipsilateral DCIS; Contralateral IDC | NA |
|
Morimoto et al. [31] | 49 | MPT | 110 | | LCIS | Contralateral | LCIS within contralateral FA | AW at 132 months |
Christensen et al. [11] | 42–58 | MPT | | | LCIS | Ipsilateral | | RIP after 12 months from metastatic PT |
Huntrakoon [32] | 31 | MPT | 90 | IDC | DCIS | Ipsilateral | | AW at 24 months |
Seemayer et al. [33] | 27 | Stromal sarcoma*** | 60 | | DCIS | Within | Liposarcomatous differentiation in PT. Contralateral MPT after initial mastectomy | NA |
|
Current case | 43 | MPT | 35 | IDC | DCIS, LCIS | Within, Ipsilateral | Liposarcomatous differentiation in PT. DCIS within PT. IDC and LCIS in ipsilateral breast. Previous radiotherapy for lymphoma. | AW at 12 months |
|